I
513.65
1.66 (0.32%)
前收盘价格 | 511.99 |
收盘价格 | 514.05 |
成交量 | 62,857 |
平均成交量 (3个月) | 873,633 |
市值 | 41,308,712,960 |
市盈率 (P/E TTM) | 47.56 |
预期市盈率 (P/E Forward) | 43.10 |
价格/销量 (P/S) | 10.94 |
股市价格/股市净资产 (P/B) | 28.87 |
52周波幅 | |
利润日期 | 4 Aug 2025 - 8 Aug 2025 |
营业毛利率 | 22.78% |
营业利益率 (TTM) | 27.42% |
稀释每股收益 (EPS TTM) | 10.66 |
季度收入增长率 (YOY) | 5.80% |
季度盈利增长率 (YOY) | 11.10% |
总债务/股东权益 (D/E MRQ) | 61.87% |
流动比率 (MRQ) | 1.31 |
营业现金流 (OCF TTM) | 929.00 M |
杠杆自由现金流 (LFCF TTM) | 734.99 M |
资产报酬率 (ROA TTM) | 22.69% |
股东权益报酬率 (ROE TTM) | 57.66% |
市场趋势
短期 | 中期 | ||
行业 | Diagnostics & Research (US) | 看跌 | 看跌 |
Diagnostics & Research (全球的) | 看跌 | 看跌 | |
股票 | IDEXX Laboratories, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
0.4
分析师共识 | 1.5 |
内部交易活动 | NA |
价格波动 | -0.5 |
技术平均移动指标 | 0.0 |
技术振荡指标 | 0.5 |
平均 | 0.38 |
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States. |
|
部门 | Healthcare |
行业 | Diagnostics & Research |
投资方式 | Mid Growth |
内部持股比例 | 0.67% |
机构持股比例 | 94.28% |
52周波幅 | ||
目标价格波幅 | ||
高 | 580.00 (Leerink Partners, 12.92%) | 购买 |
中 | 558.00 (8.63%) | |
低 | 510.00 (Stifel, -0.71%) | 保留 |
平均值 | 549.33 (6.95%) | |
总计 | 2 购买, 1 保留 | |
平均价格@调整类型 | 506.98 |
公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
---|---|---|---|---|
Leerink Partners | 11 Jun 2025 | 580.00 (12.92%) | 购买 | 524.18 |
Stifel | 19 May 2025 | 510.00 (-0.71%) | 保留 | 521.68 |
14 Apr 2025 | 420.00 (-18.23%) | 保留 | 404.65 | |
Morgan Stanley | 05 May 2025 | 558.00 (8.63%) | 购买 | 475.07 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合